- Book
- July 2025
- 256 Pages
- Book
- September 2024
- 304 Pages
- Book
- May 2024
- 464 Pages
- Book
- February 2024
- 160 Pages
- Book
- January 2024
- 496 Pages
- Book
- September 2022
- 176 Pages
- Book
- August 2022
- 352 Pages
- Book
- August 2022
- 304 Pages
- Book
- May 2022
- 512 Pages
- Book
- April 2022
- 352 Pages
- Book
- March 2022
- 896 Pages
- Book
- January 2022
- 336 Pages
- Book
- December 2020
- 432 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2020
- 640 Pages
- Book
- March 2020
- 432 Pages
- Book
- September 2019
- 1224 Pages
- Book
- January 2015
- 360 Pages
- Book
- May 2013
- 384 Pages
- Book
- September 2012
- 688 Pages

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research.
The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market.
Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more